{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:58:56Z","timestamp":1789919936396,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH381"],"award-info":[{"award-number":["ZR2023QH381"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["NO.tsqn202306356"],"award-info":[{"award-number":["NO.tsqn202306356"]}],"id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75912-1","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:02:18Z","timestamp":1729828938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Proteomic and serological markers for diagnosing cardia gastric cancer and precursor lesions in a Chinese population"],"prefix":"10.1038","volume":"14","author":[{"given":"Jiqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"issue":"9","key":"75912_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold, M., Ferlay, J., van Berge Henegouwen, M. I. & Soerjomataram, I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 69 (9), 1564\u20131571 (2020).","journal-title":"Gut"},{"issue":"8","key":"75912_CR2","doi-asserted-by":"publisher","first-page":"e2121403","DOI":"10.1001\/jamanetworkopen.2021.21403","volume":"4","author":"R Xia","year":"2021","unstructured":"Xia, R. et al. Estimated cost-effectiveness of endoscopic screening for upper gastrointestinal tract cancer in high-risk areas in China. JAMA Netw. Open. 4(8), e2121403 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"12","key":"75912_CR3","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1016\/S2468-2667(23)00186-X","volume":"8","author":"C Xia","year":"2023","unstructured":"Xia, C. et al. Cancer screening in China: A steep road from evidence to implementation. Lancet Public. Health 8(12), e996\u2013e1005 (2023).","journal-title":"Lancet Public. Health"},{"issue":"7","key":"75912_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jjco\/hyy077","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima, C. Update version of the Japanese guidelines for gastric Cancer screening. Jpn. J. Clin. Oncol. 48 (7), 673\u2013683 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"75912_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5009\/gnl19091","volume":"14","author":"SM Baek","year":"2020","unstructured":"Baek, S. M. et al. Role of serum pepsinogen II and Helicobacter pylori Status in the detection of diffuse-type early gastric Cancer in Young individuals in South Korea. Gut Liver. 14 (4), 439\u2013449 (2020).","journal-title":"Gut Liver"},{"issue":"7","key":"75912_CR6","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/cancers13071664","volume":"13","author":"AD Ricci","year":"2021","unstructured":"Ricci, A. D. et al. Novel HER2-directed treatments in advanced gastric carcinoma: AnotHER paradigm shift. Cancers (Basel) 13(7), 1664 (2021).","journal-title":"Cancers (Basel)"},{"issue":"12","key":"75912_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven, D. C. et al. Immune checkpoint inhibitor-related hearing loss: A systematic review and analysis of individual patient data. Support Care Cancer 31(12), 624 (2023).","journal-title":"Support Care Cancer"},{"issue":"6","key":"75912_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00262-023-03366-x","volume":"72","author":"A Rizzo","year":"2023","unstructured":"Rizzo, A. et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study. Cancer Immunol. Immunother 72(6), 1381\u20131394 (2023).","journal-title":"Cancer Immunol. Immunother"},{"issue":"2","key":"75912_CR9","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.2217\/fon-2019-0429","volume":"16","author":"A Rizzo","year":"2020","unstructured":"Rizzo, A. et al. Third- and later-line treatment in advanced or metastatic gastric cancer: A systematic review and meta-analysis. Future Oncol. 16(2), 4409\u20134418 (2020).","journal-title":"Future Oncol."},{"issue":"8","key":"75912_CR10","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms22083805","volume":"22","author":"K Rihawi","year":"2021","unstructured":"Rihawi, K. et al. Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications. Int. J. Mol. Sci. 22(8), 3805 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"75912_CR11","first-page":"352","volume":"13","author":"E Vitale","year":"2024","unstructured":"Vitale, E., Rizzo, A., Santa, K. & Jirillo, E. Associations between \u201ccancer risk\u201d, \u201cinflammation\u201d and \u201cmetabolic syndrome\u201d: A scoping review. Biology (Basel) 13(5), 352 (2024).","journal-title":"Biology (Basel)"},{"issue":"1","key":"75912_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1021\/acs.jproteome.0c00641","volume":"20","author":"A Petrera","year":"2021","unstructured":"Petrera, A. et al. Multiplatform approach for plasma proteomics: Complementarity of Olink proximity extension assay technology to mass spectrometry-based protein profiling. J. Proteome Res. 20(1), 751\u2013762 (2021).","journal-title":"J. Proteome Res."},{"key":"75912_CR13","unstructured":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of Disease Study 2021. Lancet 2024, S0140-6736(24)00367-2 [pii]."},{"issue":"3","key":"75912_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jgg.2022.12.005","volume":"50","author":"J Liang","year":"2023","unstructured":"Liang, J. et al. VSOLassoBag: A variable-selection oriented LASSO bagging algorithm for biomarker discovery in omic-based translational research. J. Genet. Genom. 50(3), 151\u2013162 (2023).","journal-title":"J. Genet. Genom."},{"issue":"5","key":"75912_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/jcm8050657","volume":"8","author":"CS Bang","year":"2019","unstructured":"Bang, C. S., Lee, J. J. & Baik, G. H. Prediction of chronic atrophic gastritis and gastric neoplasms by serum pepsinogen assay: A systematic review and Meta-analysis of Diagnostic Test Accuracy. J. Clin. Med. 8(5), 657 (2019).","journal-title":"J. Clin. Med."},{"issue":"2","key":"75912_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.33801","volume":"150","author":"P Gao","year":"2022","unstructured":"Gao, P. et al. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China. Int. J. Cancer. 150 (2), 243\u2013252 (2022).","journal-title":"Int. J. Cancer"},{"issue":"7","key":"75912_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/gut.2006.114504","volume":"56","author":"S Hansen","year":"2007","unstructured":"Hansen, S. et al. Two distinct aetiologies of cardia cancer; Evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 56(7), 918\u2013925 (2007).","journal-title":"Gut"},{"issue":"Suppl_1","key":"75912_CR18","doi-asserted-by":"publisher","first-page":"e12638","DOI":"10.1111\/hel.12638","volume":"24","author":"M Chmiela","year":"2019","unstructured":"Chmiela, M., Kupcinskas, J. & Review,. Pathogenesis of Helicobacter pylori infection. Helicobacter 24(Suppl_1), e12638 (2019).","journal-title":"Helicobacter"},{"issue":"12","key":"75912_CR19","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: acase-cohort study. Lancet Public. Health 6 (12), e888\u2013e896 (2021).","journal-title":"Lancet Public. Health"},{"issue":"9","key":"75912_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/ijc.33720","volume":"149","author":"J Gu","year":"2021","unstructured":"Gu, J. et al. Surveillance of premalignant gastric cardia lesions: a population-based prospective cohort study in China. Int. J. Cancer 149 (9), 1639\u20131648 (2021).","journal-title":"Int. J. Cancer"},{"issue":"37","key":"75912_CR21","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","volume":"25","author":"BB de Brito","year":"2019","unstructured":"de Brito, B. B. et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J. Gastroenterol. 25 (37), 5578\u20135589 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"75912_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11427-017-9175-2","volume":"60","author":"X Li","year":"2017","unstructured":"Li, X., Wang, W. & Chen, J. Recent progress in mass spectrometry proteomics for biomedical research. Sci. China Life Sci. 60 (10), 1093\u20131113 (2017).","journal-title":"Sci. China Life Sci."},{"key":"75912_CR23","doi-asserted-by":"publisher","first-page":"104340","DOI":"10.1016\/j.ebiom.2022.104340","volume":"86","author":"H Fan","year":"2022","unstructured":"Fan, H. et al. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer. EBioMedicine 86, 104340 (2022).","journal-title":"EBioMedicine"},{"key":"75912_CR24","doi-asserted-by":"publisher","first-page":"103714","DOI":"10.1016\/j.ebiom.2021.103714","volume":"74","author":"X Li","year":"2021","unstructured":"Li, X. et al. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. EBioMedicine 74, 103714 (2021).","journal-title":"EBioMedicine"},{"key":"75912_CR25","doi-asserted-by":"crossref","unstructured":"Gu, J., Li, S. X. X. & Xue, Z. W. L. SW. Identification of plasma proteomic signatures associated with the progression of cardia gastric cancer and precancerous lesions. J. Natl.\u00a0 (2023).","DOI":"10.1016\/j.jncc.2023.10.003"},{"key":"75912_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ebiom.2019.05.044","volume":"44","author":"Q Shen","year":"2019","unstructured":"Shen, Q. et al. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer. EBioMedicine. 44, 322\u2013333 (2019).","journal-title":"EBioMedicine"},{"key":"75912_CR27","doi-asserted-by":"publisher","first-page":"119675","DOI":"10.1016\/j.cca.2024.119675","volume":"558","author":"T Feng","year":"2024","unstructured":"Feng, T., Jie, M., Deng, K., Yang, J. & Jiang, H. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer. Clin. Chim. Acta. 558, 119675 (2024).","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"75912_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.7150\/jca.27663","volume":"10","author":"Z Xia","year":"2019","unstructured":"Xia, Z. et al. Cadherin related family member 2 acts as a tumor suppressor by inactivating AKT in human hepatocellular carcinoma. J. Cancer 10(4), 864\u2013873 (2019).","journal-title":"J. Cancer"},{"issue":"10","key":"75912_CR29","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","volume":"76","author":"PM Challita-Eid","year":"2016","unstructured":"Challita-Eid, P. M. et al. Enfortumab vedotin antibody-drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models. Cancer Res. 76(10), 3003\u20133013 (2016).","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"75912_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-020-03803-w","volume":"473","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation. Mol. Cell. Biochem. 473 (1\u20132), 1\u201313 (2020).","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"75912_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tibs.2018.12.007","volume":"44","author":"P Icard","year":"2019","unstructured":"Icard, P., Fournel, L., Wu, Z., Alifano, M. & Lincet, H. Interconnection between metabolism and cell cycle in Cancer. Trends Biochem. Sci. 44 (6), 490\u2013501 (2019).","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"75912_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12032-013-0644-2","volume":"30","author":"EN Suspitsin","year":"2013","unstructured":"Suspitsin, E. N. et al. Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence. Med. Oncol. 30 (3), 644 (2013).","journal-title":"Med. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75912-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75912-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75912-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:05:17Z","timestamp":1729829117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75912-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75912"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75912-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25309"}}